Skip to main content

Gyrodyne, LLC

corporate_fare Company Profile

Gyrodyne, LLC

GYRO·NASDAQ·Real Estate·CIK 0001589061

Gyrodyne, LLC is a New York-based limited liability company primarily engaged in managing a portfolio of medical office and industrial properties. The company also focuses on obtaining entitlements for these properties, which are located in Suffolk ("Flowerfield") and Westchester ("Cortlandt Manor") Counties, New York. The majority of Gyrodyne's developed properties are leased under agreements where tenants reimburse the company for a portion, all, or substantially all of the costs and/or cost increases related to utilities, insurance, repairs, maintenance, and real estate taxes. However, some leases stipulate that Gyrodyne is responsible for certain operating expenses. Gyrodyne's corporate strategy aims to increase the value of its Flowerfield and Cortlandt Manor properties. This is achieved by pursuing entitlement opportunities to offer purchasers greater development flexibility and by enhancing the value of its existing leases. The real estate value reported in the consolidated statement of net assets as of December 31, 2025, and December 31, 2024, reflects some, but not all, of the potential value impact from these enhancement efforts. Gyrodyne intends to dissolve after selling all its real property assets, using the proceeds to settle any debts and claims, and then distributing the remainder to common shareholders.

Gyrodyne, LLC (NASDAQ:GYRO) is a publicly traded company in the Real Estate sector. Wiseek monitors GYRO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Gyrodyne, LLC Reports Significant Decline in Net Assets and Extends Liquidation Timeline to 2028 Amid Financial Strain and High-Interest Debt
  • Gyrodyne Amends Property Sale Agreement, Grants $1.52M Credit to Buyer, Adds New Termination Risk

Financial Snapshot

Fiscal year ended December 31, 2025
Cash & Equivalents
$4.53M
Shares Outstanding
2.2M sh
Source: 10-K · filed 2026-03-27 · accession 0001437749-26-010078
Browse all tickers starting with G →
$6.17
52-week range · as of 2026-03-27 $6.8 – $12
Market cap
$13.57M
Volume
348 (0.1× avg)
3-mo avg 2.5K
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GYRO - Latest Insights

GYRO
Mar 27, 2026, 4:00 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $7.99
Real-time Price: $6.17 info
Change: -$1.82 (-23%) info
Market Cap: $13.57M info
GYRO
Jan 12, 2026, 5:26 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.06
Real-time Price: $6.17 info
Change: -$2.89 (-32%) info
Market Cap: $13.57M info